z-logo
open-access-imgOpen Access
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
Author(s) -
Prerna Arora,
Amy Kempf,
Inga Nehlmeier,
Luise Graichen,
Martin Sebastian Winkler,
Martin Lier,
Sebastian Schulz,
HansMartin Jäck,
Anne Cossmann,
Metodi V. Stankov,
Georg M. N. Behrens,
Stefan Pöhlmann,
Markus Hoffmann
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110754
Subject(s) - neutralization , antibody , virology , spike protein , vaccination , biology , covid-19 , immune escape , immunology , immune system , medicine , infectious disease (medical specialty) , disease , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom